USD 16.99
(3.98%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -100.2 Million USD | -141.22% |
2022 | 243.1 Million USD | -7.74% |
2021 | 263.5 Million USD | 691.29% |
2020 | 33.3 Million USD | -84.7% |
2019 | 217.6 Million USD | -5.68% |
2018 | 230.7 Million USD | -23.38% |
2017 | 301.1 Million USD | 10.7% |
2016 | 272 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 23.6 Million USD | 110.86% |
2024 Q2 | -1.15 Billion USD | -4979.66% |
2024 Q3 | 8.2 Million USD | 100.71% |
2023 FY | -100.2 Million USD | -141.22% |
2023 Q3 | 21.5 Million USD | -58.57% |
2023 Q2 | 51.9 Million USD | 18.49% |
2023 Q1 | 43.8 Million USD | -40.41% |
2023 Q4 | -217.4 Million USD | -1111.16% |
2022 FY | 243.1 Million USD | -7.74% |
2022 Q4 | 73.5 Million USD | 54.41% |
2022 Q3 | 47.6 Million USD | 1.06% |
2022 Q2 | 47.1 Million USD | -37.12% |
2022 Q1 | 74.9 Million USD | -12.7% |
2021 Q2 | 90.1 Million USD | 25.66% |
2021 FY | 263.5 Million USD | 691.29% |
2021 Q3 | 80.2 Million USD | -10.99% |
2021 Q1 | 71.7 Million USD | -33.86% |
2021 Q4 | 85.8 Million USD | 6.98% |
2020 Q3 | 35.6 Million USD | 138.07% |
2020 Q4 | 108.4 Million USD | 204.49% |
2020 FY | 33.3 Million USD | -84.7% |
2020 Q1 | -17.2 Million USD | -130.66% |
2020 Q2 | -93.5 Million USD | -443.6% |
2019 Q2 | 61.5 Million USD | 62.27% |
2019 FY | 217.6 Million USD | -5.68% |
2019 Q3 | 62.1 Million USD | 0.98% |
2019 Q1 | 37.9 Million USD | -25.98% |
2019 Q4 | 56.1 Million USD | -9.66% |
2018 Q3 | 64.1 Million USD | -18.65% |
2018 Q1 | 36.6 Million USD | 0.0% |
2018 Q2 | 78.8 Million USD | 115.3% |
2018 Q4 | 51.2 Million USD | -20.12% |
2018 FY | 230.7 Million USD | -23.38% |
2017 FY | 301.1 Million USD | 10.7% |
2016 FY | 272 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alcon Inc. | 974 Million USD | 110.287% |
AptarGroup, Inc. | 284.48 Million USD | 135.221% |
Baxter International Inc. | 2.65 Billion USD | 103.773% |
Becton, Dickinson and Company | 1.72 Billion USD | 105.805% |
Bausch + Lomb Corporation | -260 Million USD | 61.462% |
Haemonetics Corporation | 117.55 Million USD | 185.235% |
ResMed Inc. | 1.02 Billion USD | 109.814% |
Teleflex Incorporated | 356.32 Million USD | 128.12% |
Warby Parker Inc. | -63.19 Million USD | -58.552% |
West Pharmaceutical Services, Inc. | 593.4 Million USD | 116.886% |